Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
H tr iu tr vn ng c thy ngn, vim ty cp, chy mu di nhn
Sermorelin and CJC-1295 are not FDA-approved for anti-aging or body composition purposes
Some peptide combinations may interact unfavorably
Phase 3: Maintenance (week 13 and beyond) By this point, your digestive system has largely adapted to both the medication and fiber supplementation
Lei WS, Kilberg MJ, Zemel BS, et al
US$ 26.45
US$ 25.63
US$ 29.32
US$ 26.63
US$ 22.13
US$ 20.58
US$ 26.79
US$ 25.71
US$ 23.56
US$ 21.21
US$ 28.90
US$ 27.61
US$ 24.08
US$ 23.45
US$ 28.07
